3b Blackbio Dx Ltd vs Medinova Diagnostic Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1332 as of 23 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 29 on March 2025 . This represents a CAGR of 72.48% over 5 yearsThe P/E Ratio of Medinova Diagnostic Services Ltd(Merged) changed from 11.3 on March 2021 to 20 on March 2025 . This represents a CAGR of 12.10% over 5 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 1387 crore on March 2025 . This represents a CAGR of 45.37% over 5 yearsThe Market Cap of Medinova Diagnostic Services Ltd(Merged) changed from ₹ 22.86 crore on March 2021 to ₹ 37.95 crore on March 2025 . This represents a CAGR of 10.67% over 5 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Medinova Diagnostic Services Ltd(Merged) for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Medinova Diagnostic Services Ltd(Merged) for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Medinova Diagnostic Services Ltd(Merged) changed from ₹ 0.42 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Medinova Diagnostic Services Ltd(Merged) changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Medinova Diagnostic Services Ltd

Medinova Diagnostic Services Limited (MDSL), incorporated in 1985, commenced business on 26 March, 1993.
It belongs to Standard Organics Group.
The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology. MDSL has acquired the business and undertaking of the diagnostic services division of Standard Medical & Pharmaceuticals (SMPL) as a going concern together with assets and liabilities from 1 Apr.'93.
It has four main diagnostic centres in Hyderabad, Bangalore, Pune, and Kolkata apart from mini/medium-sized franchise centres at Karimnagar, Mancherial, Vizag, Nellore. MDSL came out with a public issue of 67.50 lac equity shares at par, aggregating Rs 6.

FAQs for the comparison of 3B Blackbio DX Ltd and null

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Medinova Diagnostic Services Ltd?

Market cap of 3B Blackbio DX Ltd is 1,144 Cr while Market cap of Medinova Diagnostic Services Ltd is 43 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Medinova Diagnostic Services Ltd?

The stock performance of 3B Blackbio DX Ltd and Medinova Diagnostic Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Medinova Diagnostic Services Ltd?

As of October 24, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1332.95. On the other hand, Medinova Diagnostic Services Ltd stock price is INR ₹43.45.

How do dividend payouts of 3B Blackbio DX Ltd and Medinova Diagnostic Services Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Medinova Diagnostic Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.